BE904662A - Derive antipsychotique du benzisothiazole s-oxyde. - Google Patents
Derive antipsychotique du benzisothiazole s-oxyde.Info
- Publication number
- BE904662A BE904662A BE0/216581A BE216581A BE904662A BE 904662 A BE904662 A BE 904662A BE 0/216581 A BE0/216581 A BE 0/216581A BE 216581 A BE216581 A BE 216581A BE 904662 A BE904662 A BE 904662A
- Authority
- BE
- Belgium
- Prior art keywords
- antipsychotic
- benzisothiazole
- derivative
- oxide
- compound
- Prior art date
Links
- KANAPVJGZDNSCZ-UHFFFAOYSA-N 1,2-benzothiazole 1-oxide Chemical class C1=CC=C2S(=O)N=CC2=C1 KANAPVJGZDNSCZ-UHFFFAOYSA-N 0.000 title 1
- 230000000561 anti-psychotic effect Effects 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 2
- 239000011707 mineral Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Procédé de préparation d'un composé de formule (1) ou de ses sels d'addition d'acides pharmaceutiquement acceptables, qui consiste à faire réagir un composé de formule (2) avec un mélange d'acides minéraux à une température inférieure à environ 5 degrés C et, si on le souhaite, à en former le sel pharmaceutiquement acceptable par réaction du produit final basique avec un acide organique ou minéral choisi, pour obtenir un agent antipsychotique présentant moins d'effets secondaires genants.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/726,449 US4656173A (en) | 1985-04-24 | 1985-04-24 | Antipsychotic benzisothiazole S-oxide compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE904662A true BE904662A (fr) | 1986-10-23 |
Family
ID=24918649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/216581A BE904662A (fr) | 1985-04-24 | 1986-04-23 | Derive antipsychotique du benzisothiazole s-oxyde. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4656173A (fr) |
| JP (1) | JPH0764842B2 (fr) |
| KR (1) | KR900000372B1 (fr) |
| CN (1) | CN1017528B (fr) |
| AT (1) | AT394719B (fr) |
| AU (1) | AU592787B2 (fr) |
| BE (1) | BE904662A (fr) |
| CA (1) | CA1247102A (fr) |
| CH (1) | CH666034A5 (fr) |
| DE (1) | DE3613739C2 (fr) |
| DK (1) | DK187686A (fr) |
| EG (1) | EG18002A (fr) |
| ES (1) | ES8708228A1 (fr) |
| FI (1) | FI84604C (fr) |
| FR (1) | FR2581064B1 (fr) |
| GB (1) | GB2174393B (fr) |
| GR (1) | GR861063B (fr) |
| HU (1) | HU195654B (fr) |
| IE (1) | IE59182B1 (fr) |
| IT (1) | IT1208600B (fr) |
| LU (1) | LU86405A1 (fr) |
| MY (1) | MY102041A (fr) |
| NL (1) | NL8601043A (fr) |
| PT (1) | PT82450B (fr) |
| SE (1) | SE462163B (fr) |
| ZA (1) | ZA861531B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4780466A (en) * | 1988-03-17 | 1988-10-25 | Hoechst-Roussel Pharmaceuticals, Inc. | Arylpiperazinylalkoxy derivatives of cyclic imides |
| EP0350145A3 (fr) * | 1988-04-28 | 1990-07-04 | Yamanouchi Pharmaceutical Co. Ltd. | Derivés de Pyridylthiazolidine carboxamide et intermédiaires et leur production |
| WO1990002552A1 (fr) * | 1988-09-16 | 1990-03-22 | Pfizer Inc. | Imides bicycliques polynucleaires de 4-[4-(3-benzisothiazolyl)-1-piperazinyl]butyle a usage antipsychotique |
| US4956368A (en) * | 1989-07-24 | 1990-09-11 | Bristol-Myers Company | Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione |
| US4968792A (en) * | 1989-09-25 | 1990-11-06 | American Home Products Corporation | Psychotropic benzisothiazole derivatives |
| US5162321A (en) * | 1989-12-20 | 1992-11-10 | Adir Et Compagnie | 1-naphthyl piperazines useful as 5-HT1A receptor ligands |
| JP2800953B2 (ja) * | 1990-07-06 | 1998-09-21 | 住友製薬株式会社 | 新規なイミド誘導体 |
| HK1215170A1 (zh) | 2012-11-14 | 2016-08-19 | The Johns Hopkins University | 治療精神分裂症的方法和組合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
| US3976776A (en) * | 1972-12-06 | 1976-08-24 | Mead Johnson & Company | Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones |
| CH582699A5 (fr) * | 1973-03-26 | 1976-12-15 | Sandoz Ag | |
| AT342057B (de) * | 1974-04-25 | 1978-03-10 | Thomae Gmbh Dr K | Verfahren zur herstellung von neuen 3-piperazino-isochinolinen und deren salzen |
| FI753625A7 (fr) * | 1975-01-06 | 1976-07-07 | Spofa Vereinigte Pharma Werke | |
| JPS51144735A (en) * | 1975-06-06 | 1976-12-13 | Nippon Nohyaku Co Ltd | A remedy for hepatic failure |
| US4411901A (en) * | 1981-12-23 | 1983-10-25 | Mead Johnson & Company | Benzisothiazole and benzisoxazole piperazine derivatives |
| US4452799A (en) * | 1981-12-23 | 1984-06-05 | Mead Johnson & Company | Benzisothiazole and benzisoxazole piperazine derivatives |
| US4524206A (en) * | 1983-09-12 | 1985-06-18 | Mead Johnson & Company | 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives |
-
1985
- 1985-04-24 US US06/726,449 patent/US4656173A/en not_active Expired - Lifetime
-
1986
- 1986-02-21 CA CA000502439A patent/CA1247102A/fr not_active Expired
- 1986-02-28 ZA ZA861531A patent/ZA861531B/xx unknown
- 1986-04-02 KR KR1019860002515A patent/KR900000372B1/ko not_active Expired
- 1986-04-15 AU AU56121/86A patent/AU592787B2/en not_active Ceased
- 1986-04-20 EG EG232/86A patent/EG18002A/xx active
- 1986-04-21 FI FI861668A patent/FI84604C/fi not_active IP Right Cessation
- 1986-04-22 FR FR8605789A patent/FR2581064B1/fr not_active Expired
- 1986-04-22 GR GR861063A patent/GR861063B/el unknown
- 1986-04-23 IT IT8620187A patent/IT1208600B/it active
- 1986-04-23 GB GB08609932A patent/GB2174393B/en not_active Expired
- 1986-04-23 LU LU86405A patent/LU86405A1/fr unknown
- 1986-04-23 CH CH1685/86A patent/CH666034A5/de not_active IP Right Cessation
- 1986-04-23 DE DE3613739A patent/DE3613739C2/de not_active Expired - Fee Related
- 1986-04-23 NL NL8601043A patent/NL8601043A/nl active Search and Examination
- 1986-04-23 ES ES554284A patent/ES8708228A1/es not_active Expired
- 1986-04-23 BE BE0/216581A patent/BE904662A/fr not_active IP Right Cessation
- 1986-04-23 DK DK187686A patent/DK187686A/da not_active Application Discontinuation
- 1986-04-23 PT PT82450A patent/PT82450B/pt not_active IP Right Cessation
- 1986-04-23 SE SE8601883A patent/SE462163B/sv not_active IP Right Cessation
- 1986-04-23 IE IE108386A patent/IE59182B1/en not_active IP Right Cessation
- 1986-04-23 CN CN86102742A patent/CN1017528B/zh not_active Expired
- 1986-04-24 HU HU861704A patent/HU195654B/hu not_active IP Right Cessation
- 1986-04-24 JP JP61095859A patent/JPH0764842B2/ja not_active Expired - Lifetime
- 1986-04-24 AT AT0110486A patent/AT394719B/de not_active IP Right Cessation
-
1987
- 1987-09-28 MY MYPI87002086A patent/MY102041A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5212204A (en) | Antihypertensive compositions and use thereof | |
| EP0274453A3 (fr) | Nouveaux composés à activité d'inhibiteurs de collagénase, procédé pour les préparer et compositions pharmaceutiques contenant ces composés | |
| HUT37780A (en) | Process for producing n-/4-piperidyl/-substituted bicyclic condensed 2-imidazolyl-amine derivatives and pharmaceutical compositions containing them as active agents | |
| DE3562374D1 (en) | Compound having antibronchopneumopathic activity, process for its preparation and pharmaceutical compositions containing it | |
| AR240830A2 (es) | Procedimiento para preparar derivados de acidos naftiridin quinolin-y benzoxazincarboxilicos. | |
| SE9000282L (sv) | 6-brom-5-hydroxi-4-dimetylaminometyl-1-metyl-2-fenyltiometylindol-3-karbonsyra etylester-hydroklorid i monohydratform, foerfarande foer framstaellning av densamma och paa hydrokloriden i monohydratform baserat laekemedelspreparat med antivirusverkan interferoninducerande och immunomodulerande verkan | |
| BE904662A (fr) | Derive antipsychotique du benzisothiazole s-oxyde. | |
| CZ282036B6 (cs) | Nové 3-cykloalkylpropanamidy, jejich tautomerní formy a jejich soli, způsob jejich přípravy a použití jako léčiv a kompozice tyto 3-cykloalkyl propanamidy obsahující | |
| EP0870761B1 (fr) | Dérivés de thiocolchicine ayant une activité antiinfammatoire et relaxante des muscles | |
| DK0430201T3 (fr) | ||
| Barton et al. | The invention of new radical chain reactions: part XIII. Generation and reactivity of perfluoroalkyl radicals from thiohydroxamic esters | |
| GR3026186T3 (en) | Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors | |
| HUT46895A (en) | Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect | |
| FI900365A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-fenyyli-5,6-dihydrobents/C/akridiini-7-karboksyylihappojohdannnaisten valmistamiseksi | |
| EP0059108B1 (fr) | Dérivés d'acide dihydroxibenzoique | |
| KR880007556A (ko) | 새로운 안트라시클린 유도체와 이의 제조 방법 | |
| BE905409A (fr) | Procede de preparation de n-sulfamyl-3-(2-guanidino-thiazol-4-yl-methylthio)-propionamidine. | |
| ZA842423B (en) | Compounds with antiinflammatory activity,process for preparation thereof and pharmaceutical compositions therefrom | |
| US4125711A (en) | Process for preparing auranofin | |
| EP0204172B1 (fr) | Dérivés de phénylpyrazine, leurs procédés de préparation, composition pharmaceutique at utilisation | |
| CH634075A5 (en) | Process for the preparation of hydrated imidazothiazole and thiazolopyrimidine derivatives having an anti-inflammatory activity | |
| ATE19781T1 (de) | Androstenen enthaltenden pharmazeutische zusammensetzungen. | |
| EP0371837A3 (fr) | Procédé de synthèse spécifique de nouveaux esters d'acides dithiocarbamiques par substitution de sites hydroxylés sur des molécules mono- ou polyhydroxylées produits obtenus for ce procédé et leurs applications | |
| FR2415641A1 (fr) | Amino-3-cardenolides, procede pour leur preparation, et medicaments les contenant | |
| FR2396761A1 (fr) | Procede de preparation du r,s-2,3,5,6-tetrahydro-6-phenyl-imidazo (2,1-b)-thiazole et de ses sels d'addition d'acide pharmaceutiquement acceptables, mettant en oeuvre un alkylxanthogenate ou du thiophene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: BRISTOL-MYERS CY Effective date: 20000430 |